PYRIDAZINYLAMINODERIVATE ALS ALK5-INHIBITOREN

European patent · EP4182308 · In force

Register entry

Publication number
EP4182308
Application number
EP21743186
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 14, 2021
Published
May 24, 2023
Granted
Sep 4, 2024
Protection ends at the latest
Jul 13, 2041
Next annual fee due
Jul 31, 2026
IPC classes
C07D 401/12 (2006.01)
C07D 471/04 (2006.01)
A61K 31/501 (2006.01)
A61P 11/00 (2006.01)
Priority
EP 20185890 15.07.2020
PCT application
PCT/EP2021/069649 14.07.2021
PCT publication
WO2022/013307 20.01.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2025

    Change

    Published in Swissreg on 01.08.2025

  2. Jul 16, 2025

    Change

    Published in Swissreg on 16.07.2025

  3. Nov 6, 2024

    Agent entered

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 06.11.2024

  4. Sep 4, 2024

    Granted

    Published in Swissreg on 04.09.2024

Parties

Holder

Chiesi Farmaceutici S.p.A.

Via Palermo, 26/A, 43122 Parma, IT

Agent

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventor

BERTANI, Barbara

43122 Parma, IT

GUARIENTO, Sara

43122 Parma, IT

BIAGETTI, Matteo

43122 Parma, IT

RONCHI, Paolo

43122 Parma, IT

BRUNO, Paolo

43122 Parma, IT

BARILLI, Alessio

43122 Parma, IT

PALA, Daniele

43122 Parma, IT

PIZZIRANI, Daniela

43122 Parma, IT

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.